ArticleFEMS microbiology letters2025
Golden oats - Natural fortification of oat milk with riboflavin through fermentation.
Article in FEMS microbiology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Isolation, Fermentation, and Application of Probiotics Derived from Fermented Grains.Journal of agricultural and food chemistry · 2026Review
- Riboflavin production by lactic acid bacteria: a mini-review.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Plant-based beverages are often fortified with different vitamins, especially B-vitamins, as the raw materials used for their production have a low content of these. Recently, we reported a simple and natural approach for obtaining vitamin B2 (riboflavin) secreting derivatives of the lactic acid bacterium (LAB) Lactococcus lactis, based on the observation that riboflavin can alleviate heat-induced oxidative stress. Here, we explore the potential of these strains for enriching plant-based beverages based on soy and oats, with riboflavin. Three riboflavin producing L. lactis strains were selected for the study: ER10, ALE13, and LDH13, where the latter is a lactate dehydrogenase-deficient derivative of ALE13. We found that ER10 produced more than 50 % more riboflavin in soy milk than ALE13 under static conditions (i.e. with no active aeration). Aerated culturing, in general, increased riboflavin production, especially for LDH13. The protein in oat milk is mostly insoluble and thus unavailable for the L. lactis strains used. To address this, oat milk was treated with food grade proteases, Alcalase® and Flavourzyme®, generating soluble peptides. When LDH13 was grown in the enzymatically treated oat milk with aeration, this resulted in a 600 % increase in riboflavin content (∼6 mg/L), demonstrating that the bioavailability of amino acids limits riboflavin production in oat milk. Here, we found that arginine played a special role in riboflavin production. By supplementing enzymatically treated oat milk with arginine, the riboflavin content could be further increased to 8 mg/L.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.